Barinthus Biotherapeutics plc. Annual Operating Lease, Payments in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Operating Lease, Payments history and growth rate from 2020 to 2023.
  • Barinthus Biotherapeutics plc. Operating Lease, Payments for the quarter ending March 31, 2024 was $346K, a 57.3% increase year-over-year.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2023 was $639K, a 40.9% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2022 was $1.08M, a 227% increase from 2021.
  • Barinthus Biotherapeutics plc. annual Operating Lease, Payments for 2021 was $331K, a 9.97% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $639K -$442K -40.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $1.08M +$750K +227% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $331K +$30K +9.97% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-24
2020 $301K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.